🇺🇸 FDA
Pipeline program

Aflibercept Injection

VOYAGE

Approved small_molecule completed

Quick answer

Aflibercept Injection for Diabetic Retinopathy is a Approved program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Diabetic Retinopathy
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials